Menu
Not yet recruiting NCT07650487

Perioperative Myocardial Injury in Patients Undergoing Coronary Artery Bypass Grafting: A Prospective Clinical Study

Observational Myocardial Injury Coronary Artery Disease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: High-Sensitivity Troponin, Cardiac MRI.
Who it may be relevant to
Registry conditions: Myocardial Injury, Coronary Artery Disease. Basic parameters: 21 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Prospective Clinical Study for Evaluation of Perioperative Myocardial Injury Using High-Sensitivity Troponin and Cardiac MRI in Patients Undergoing Coronary Artery Bypass Grafting (CABG)

Overview

Perioperative myocardial injury (PMI) following coronary artery bypass grafting (CABG) is associated with postoperative morbidity, mortality, and long-term outcomes. High-sensitivity troponin assays and cardiac MRI offer reliable diagnostic tools for PMI, but evidence regarding optimal diagnostic thresholds and perioperative imaging strategy is limited. This prospective clinical study aims to determine the incidence of perioperative myocardial injury using multimodal assessments including high-sensitivity troponin, electrocardiogram, echocardiography, cardiac MRI, and perioperative cardiovascular events.

Interventions

  • Diagnostic test High-Sensitivity Troponin
    High-sensitivity troponin levels are measured preoperatively, predischarge, and at 6-month follow-up to assess perioperative myocardial injury.
  • Diagnostic test Cardiac MRI
    A diagnostic assessment panel including high-sensitivity troponin testing, electrocardiography, echocardiography, and cardiac magnetic resonance imaging performed during the perioperative period.

Primary outcome measures

  • Incidence of Perioperative Myocardial Injury (PMI) [Time frame: Within 48 hours post-CABG]

Eligibility criteria

Inclusion criteria

  • Age ≥ 21 years
  • Undergoing CABG for unstable angina
  • Able to provide written informed consent
  • No major cardiovascular event in the prior 6 months

Exclusion criteria

  • Significant hepatic, renal, or other major organ dysfunction
  • Pregnancy or breastfeeding
  • Withdrawal during the study
  • Contraindication to cardiac MRI (metal implants, claustrophobia, etc.)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

China · 1 center
  • the Second Hospital of Jilin University — Changchun

Identifiers

NCT: NCT07650487 · PMICABG

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗